Weitere Kapitel dieses Buchs durch Wischen aufrufen
This paper attempts to evaluate the possible gains and losses arising from the gradual opening up of pharmaceutical trade between India and Pakistan. We explain the comparative advantages of both countries at a disaggregated level, followed by a qualitative analysis of various perceptions and experiences of Pakistan’s pharmaceutical manufacturers with respect to trade with India. We find that a gradual opening up of pharmaceutical trade with India may allow Pakistan to enhance the quality of locally produced medicines through raw material, intermediate inputs, knowledge, and skills transfer from India. Pakistan, in the medium to long run, may also be able to diversify its pharmaceutical export base, reduce cost of production and achieve higher competitiveness through the development of value chain linkages with India. Such linkages are important to cater to the projected rise in demand for pharmaceuticals in Pakistan, Afghanistan and abroad.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
This paper has been written as part of research studies conducted under the project “Strengthening Research and Promoting Multi-level Dialogue for Trade Normalisation between India and Pakistan” led by Dr. Nisha Taneja. The authors are thankful to Dr. Nisha Taneja, Dr. Aradhna Aggarwal and Dr. Aparna Sawhney for comments.
The statistics here pertain to Chap. 30, i.e. pharmaceutical products, only.
All these products are listed at the 8-digit level.
Leading consumer groups from Islamabad and Karachi participated in our focus group discussion.
The organisation does not even have a website.
Aamir, M., & Zaman, K. (2011). Review of Pakistan pharmaceutical industry: SWOT analysis. International Journal of Business and Information Technology, 1(1)
Ahmed, M. (2012a). Trade of industrial goods with india: Opportunities and challenges for Pakistan. In Trade Development Authority of Pakistan.
Ahmed, S. I. (2012b). Breaking the trade barrier. Himal South-Asian. (online) Available at: http://www.himalmag.com/component/content/article/5031-.html. Accessed on November 23, 2013.
Ahmed, V., Batool, S., & Khan, S. (2013a). Pharmaceutical trade with India. India-Pakistan trade Newsletter. December 2013. In Indian council for research on international economic relations.
Ahmed, V., Batool, S., & Bhatti, U. (2013b). Pakistan’s trade with India: Case of auto sector in Pakistan. India-Pakistan trade Newsletter. January 2014. In Indian council for research on international economic relations.
Ahmed, V., Suleri, A., Wahab, A., & Javed, A. (2013c). Informal flow of merchandise from India: The case of Pakistan. New Delhi: SDPI Working Paper.
Alesina, A., Spolaore, E., & Wacziarg, R. (2005). Trade, growth and the size of countries. In Handbook of economic growth (Vol. 1). Elsevier. Amsterdam: North Holland.
Balassa, B. (1965). Trade liberalisation and revealed comparative advantage. The Manchester School, 33(2:2), 99–123
Batra, A., & Khan, Z. (2005). Revealed comparative advantage: An analysis for India and China. In ICRIER, India. Working Paper no. 168.
Board of Investment. (2012). Pakistan investment guide 2012. Government of Pakistan.
Business Monitor International. (2010). Pakistan pharmaceutical and health care report Q3 2010.
Carsten, K. (2000). Welfare and integration. International Economic Review, 41(2).
Chatterjee, B., & George, J. (2013). Reforming non-tariff barriers: Case for a participatory approach in South Asia. In Consumer unity and trust society (July 2013, pp. 132–138). India, Jaipur.
HEC. (2010–11). Annual Report. Government of Pakistan.
Hussain, I. (2011). Prospects and challenges for increasing India-Pakistan trade. Atlantic Council.
India–Pakistan Trade. (2013). Website. Accessed on: September 16, 2013.
Institute of Business Management. (2013). Pakistan business review 2013. Journal of Economic Literature, 14(4).
International Trade Centre. (2013). Trade map.
Lillah, W. (2012). MNCs have 53 % share in pharmaceutical market: National Assembly panel informed. Business Recorder. (online) Available at: http://www.brecorder.com/business-a-economy/189/1243095/. Accessed on: September 16, 2013.
Ministry of Commerce. (2013a). Website. In Government of Pakistan. Accessed on December 15, 2013.
Ministry of Commerce, Pakistan. (2013b). Website. Accessed on: October 7, 2103 http://www.commerce.gov.pk/
Mishra, A. R. (2013). SAFTA members propose to reduce sensitive list . Live mint. (online) Available at: http://www.livemint.com/Politics/fInJz4wPhBeWZd0WBGz2bO/Safta-members-propose-to-reduce-sensitive-list.html. Accessed on: September 11, 2013.
Overseas Investors Chamber of Commerce and Industry. (2011). Annual report 2011.
Picazo, O. (2011). Review of the Cheaper Medicines Program of Philippines, Philippines Institute of Development Studies.
Qamar, A. (2005). Trade between India and Pakistan: Potential items and the MFN status. State Bank of Pakistan Research Bulletin, 1(1).
SAARC Secretariat. (2013). Website. http://saarc-sec.org/areaofcooperation/detail.php?activity_id=35. Accessed on December 15, 2013.
Shahrukh, N. (2011). Pharmaceutical Industry Walking a Tightrope. In Weekly pulse. (online) Available at: http://weeklypulse.org/details.aspx?contentID=231&storylist=12. Accessed on: October 12, 2013.
State Bank of Pakistan. (2014). Pakistan custom tariff. http://www.sbp.org.pk/fe_returns/custom-tariff-07-08.pdf. Accessed on: February 16, 2014.
Taneja, N. (2013a). Additional trade challenges: Transport, transit, and non-tariff barriers. In M. Kugelman & R. Hathaway (Eds.,) Pakistan-India Trade: What Needs To Be Done? What Does It Matter? Woodrow Wilson International Center.
Taneja, N. (2013b). What’s in it for us? The potential of India Pakistan trade. In Foreign policy. (online) Available at: http://afpak.foreignpolicy.com/posts/2013/04/15/whats_in_it_for_us_the_potential_in_india_pakistan_trade_0. Accessed on October 14, 2013.
Taneja, N., Mehra, M., Mukharjee, M., Bimal, S., & Dayal, I. (2013). Normalizing Normalising India Pakistan Trade. In Indian council for research on international economic relations. Working Paper no. 267.
Times of Pakistan. (2011). Drug pricing policy-2011 finalized for approval to rationalize medicine prices. (online) Available at: http://timesofpakistan.pk/pakistan/2011-01-31/drugs-pricing-policy-2011-finalized-for-approval-to-rationalise-medicines-prices/23180/. Accessed on October 14, 2013.
Wajid, M. A. (2003). Trade with India in Pakistan’s Interest. In The Nation. (online). Accessed on October 14, 2013.
Zaidi, S., Bigdeli, M., Aleem, N., & Rashidian, A. (2013). Access to essential medicines in Pakistan: Policy and health systems research concerns. PLoS One, 8(1).
- India–Pakistan Trade: A Case Study of the Pharmaceutical Sector
- Springer Singapore
- Chapter 7
Neuer Inhalt/© Stellmach, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta